SUNNYVALE, Calif. , Jan. 19, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that between January 11 and January 15, 2016 , the company, in privately-negotiated transactions, had repurchased approximately $63.4 million in aggregate principal amount of its 3.75% Convertible
SUNNYVALE, Calif. , Oct. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the first quarter of fiscal year 2010, ended September 30, 2009 . For the first quarter of fiscal 2010, Accuray reported
Q1 Highlights: Revenue Growth and Service Gross Margin Improvement SUNNYVALE, Calif., Nov. 8, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company , announced today financial results for the first quarter of fiscal 2012 that ended September 30,
Transformative Technology Launch at Leading Radiation Oncology Meeting Sets Stage for Future Growth SUNNYVALE, Calif. , Nov. 7, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the first quarter of fiscal 2013
Inventory Investigation Concluded SUNNYVALE, Calif ., Dec. 18 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the first quarter of fiscal 2009, ended September 27, 2008 .
SUNNYVALE, Calif., Nov. 8, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the first quarter of fiscal year 2011, ended September 30, 2010. For the first quarter of fiscal 2011, Accuray reported
SUNNYVALE, Calif. , Aug. 24 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year 2009, ended June 27, 2009 . For the fourth quarter of fiscal 2009, Accuray reported total
Strong CyberKnife(R) Orders Highlight Quarter and Fiscal Year SUNNYVALE, Calif., Aug 31, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the fourth quarter and fiscal year 2010, ended June 30,
Record Revenue Set For Quarter SUNNYVALE, Calif., Sept. 19, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the fourth quarter and fiscal year ended June 30, 2011 .
Integration of TomoTherapy on Track; Company Preparing for Major Technology Releases SUNNYVALE, Calif. , Sept. 6, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the fourth quarter and fiscal year ended June
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
